Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Myeloproliferative Disorders × Exercise × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 169 Breast Neoplasms 99 Neoplasms 70 Prostatic Neoplasms 25 Fatigue 24 Colorectal Neoplasms 18 Obesity 17 Lung Neoplasms 13 Polycystic Ovary Syndrome 11 Ovarian Neoplasms 10 Lymphedema 10 Colonic Neoplasms 10 Rectal Neoplasms 9 Lymphoma 9 Multiple Myeloma 8 Hematologic Neoplasms 8 Head and Neck Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Pancreatic Neoplasms 7 Cardiotoxicity 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia 6 Insulin Resistance 6 Brain Neoplasms 6 Weight Loss 5 Sarcopenia 5 Esophageal Neoplasms 5 Endometrial Neoplasms 5 Breast Cancer Lymphedema 5 Stomach Neoplasms 4

Interventions

Cyclophosphamide 10 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 8 Cyclosporine 7 Mycophenolic Acid 6 Whole-Body Irradiation 5 Filgrastim 5 Antilymphocyte Serum 5 Radiotherapy 4 Psychiatric Rehabilitation 4 Cytarabine 4 Busulfan 4 Methylprednisolone 3 Melphalan 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 Therapeutics 2 Polymerase Chain Reaction 2 Methotrexate 2 Mesna 2 Flow Cytometry 2 Dexamethasone 2 Calcium Dobesilate 2 Aprepitant 2 Analgesia 2 sargramostim 1 plerixafor 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07384039 2026-02-05

MPN-Exercise

Hannover Medical School

Phase NA Not yet recruiting

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡